Developing EYVIVA-001, a humanised anti-FasL monoclonal antibody for Geographic Atrophy and Glaucoma
| Website | http://www.eyviva.com |
| Employees | 2 (2 on RocketReach) |
| Founded | 2024 |
| Industry | Biotechnology Research |
Looking for a particular EYVIVA employee's phone or email?
David Blakey is the Founder and CSO of EYVIVA.
2 people are employed at EYVIVA.